Microfluidics-generated pancreatic islet microfibers for enhanced immunoprotection.

Pancreatic islet transplantation is a promising method for treatment of type 1 diabetes mellitus. However, transplanted islets can be destroyed due to host immune reactions. To immunologically protect transplanted islets, here an immunoprotective microfiber including islets by using a polydimethylsiloxane (PDMS)-based microfluidic device is newly designed. A cylindrical-flow channel in the microfluidic platform is used for producing collagen-alginate composite (CAC) fibers. This enables mass production and uniform diameter distribution (<250 μm) without protruding islets. Collagen, which is the main extracellular matrix component, is added to alginate to mimic the native islet microenvironment. Compared to free islets (control) and alginate-fiber-encapsulated islets, CAC-fiber-encapsulated islets show higher viability and normal insulin secretion. When CAC-fiber-encapsulated islets (1200 islet equivalent) are implanted into the intraperitoneal cavity of streptozotocin-induced diabetic BALB/C mice, the blood glucose levels of all mice return to normoglycemia. Moreover, intraperitoneal glucose tolerance tests demonstrate that islets in the CAC-fiber have similar glucose responsiveness to those of non-diabetic normal mice. These results are attributed to the immunoprotection of the transplanted islets from host immune reactions. On the other hand, all free islets are completely rejected within a week due to severe immune responses. Collectively, fabrication of CAC fibers using microfluidic devices can be used for successful islet transplantation.

[1]  A. Manz,et al.  Lab-on-a-chip: microfluidics in drug discovery , 2006, Nature Reviews Drug Discovery.

[2]  R. Lanza,et al.  Encapsulated cell technology , 1996, Nature Biotechnology.

[3]  K. Ekdahl,et al.  Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation , 2002, The Lancet.

[4]  A. Shapiro,et al.  Advances in pancreatic islet transplantation in humans , 2006, Diabetes, obesity & metabolism.

[5]  V. Dolnik,et al.  Capillary electrophoresis on microchip , 2000, Electrophoresis.

[6]  Sang-Hoon Lee,et al.  Microfluidic wet spinning of chitosan-alginate microfibers and encapsulation of HepG2 cells in fibers. , 2011, Biomicrofluidics.

[7]  P. de Vos,et al.  Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts. , 1996, Transplantation.

[8]  Christopher B. Rives,et al.  Extracellular Matrix Protein-Coated Scaffolds Promote the Reversal of Diabetes After Extrahepatic Islet Transplantation , 2008, Transplantation.

[9]  Ali Khademhosseini,et al.  Digitally tunable physicochemical coding of material composition and topography in continuous microfibres. , 2011, Nature materials.

[10]  Dong Yun Lee,et al.  Surface modification of pancreatic islets using heparin-DOPA conjugate and anti-CD154 mAb for the prolonged survival of intrahepatic transplanted islets in a xenograft model. , 2012, Biomaterials.

[11]  J. Egan,et al.  Insulin Release and Insulin mRNA Levels in Rat Islets of Langerhans Cultured on Extracellular Matrix , 1996, Pancreas.

[12]  Emile de Heer,et al.  Integrin signaling via RGD peptides and anti-beta1 antibodies confers resistance to apoptosis in islets of Langerhans. , 2006, Diabetes.

[13]  Lorenzo Capretto,et al.  Optimised production of multifunctional microfibres by microfluidic chip technology for tissue engineering applications. , 2011, Lab on a chip.

[14]  Su-Jung Shin,et al.  Novel PDMS cylindrical channels that generate coaxial flow, and application to fabrication of microfibers and particles. , 2010, Lab on a chip.

[15]  J. Contreras,et al.  Anoikis, extracellular matrix, and apoptosis factors in isolated cell transplantation. , 1999, Surgery.

[16]  Bong Geun Chung,et al.  Microfluidic synthesis of pure chitosan microfibers for bio-artificial liver chip. , 2010, Lab on a chip.

[17]  Dong Yun Lee,et al.  In situ formation and collagen-alginate composite encapsulation of pancreatic islet spheroids. , 2012, Biomaterials.

[18]  Shinji Sakai,et al.  Novel technique to control inner and outer diameter of calcium-alginate hydrogel hollow microfibers, and immobilization of mammalian cells , 2010 .

[19]  D. Beebe,et al.  Physics and applications of microfluidics in biology. , 2002, Annual review of biomedical engineering.

[20]  L. Rosenberg,et al.  Maintenance of beta-cell function and survival following islet isolation requires re-establishment of the islet-matrix relationship. , 1999, The Journal of endocrinology.

[21]  P. Halban,et al.  Extracellular matrix protects pancreatic beta-cells against apoptosis: role of short- and long-term signaling pathways. , 2004, Diabetes.

[22]  P. Marchetti,et al.  The pancreatic beta-cell in human Type 2 diabetes. , 2006, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[23]  A. Obenaus,et al.  Factors affecting islet graft embolization in the liver of diabetic mice. , 2009, Islets.

[24]  Jin-Hee Moon,et al.  Microfluidic Spinning of Flat Alginate Fibers with Grooves for Cell‐Aligning Scaffolds , 2012, Advanced materials.

[25]  J. P. Freyer,et al.  Influence of glucose and oxygen supply conditions on the oxygenation of multicellular spheroids. , 1986, British Journal of Cancer.

[26]  A. Shapiro,et al.  Five-year follow-up after clinical islet transplantation. , 2005, Diabetes.

[27]  Ali Khademhosseini,et al.  Microfluidic chip-based fabrication of PLGA microfiber scaffolds for tissue engineering. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[28]  G. Warnock,et al.  Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal , 2011, Journal of cellular physiology.

[29]  J F Elliott,et al.  Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. , 2001, Diabetes.

[30]  A. Sun,et al.  Xenografts of rat islets into diabetic mice. An evaluation of new smaller capsules. , 1992, Transplantation.

[31]  D. Greiner,et al.  Induction of immunologic tolerance for transplantation. , 1999, Physiological reviews.

[32]  A. Mikos,et al.  Mini‐review: Islet transplantation to create a bioartificial pancreas , 1994, Biotechnology and bioengineering.

[33]  K. Jensen,et al.  Cells on chips , 2006, Nature.

[34]  J. Chapman.  Chronic Calcineurin Inhibitor Nephrotoxicity—Lest We Forget , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[35]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.